Halozyme Therapeutics
Tram Bui currently serves as Vice President of Investor Relations and Corporate Communications at Halozyme, Inc., a position held since May 2022. Previously, Tram Bui was Vice President of Corporate Communications and Investor Relations at Antares Pharma Inc. from August 2020 to May 2022, and held various senior roles at The Ruth Group, including Senior Vice President and Vice President of Investor Relations from October 2015 to August 2020. Tram Bui’s career also includes serving as Account Director for Investor Relations at KCSA Strategic Communications and Vice President of Operations at BrazilianSupplements, Inc. from 2009 to 2014. Early roles included positions in institutional equity sales at CJS Securities and as an Equity Research Analyst at Lazard Asset Management from 2001 to 2009. Tram Bui earned a Bachelor of Science degree from the University of New Orleans and has continued education at Louisiana State University, along with experiences at the University of Innsbruck and Benjamin Franklin High School.
This person is not in any teams
This person is not in any offices
Halozyme Therapeutics
7 followers
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.